Novartis gets final U.S. approval for Exforge

(Reuters) - The FDA had already granted Novartis tentative approval in
December. Exforge was approved in January 2007 in the European
Union and has already been made available in nine EU countries,
with further launches planned.




Read more at Reuters.com Government Filings News

U.S. court rejects Novartis motion on patent case

(Reuters) - The U.S. Court of Appeals for the Federal Circuit denied a Novartis request to review the reinstatement of the patent challenge by Teva Pharmaceutical Industries Ltd. .



The appeals court, in a brief notice on its Web site, said it turned down a Novartis request to have a panel of judges rehear a March ruling in Teva's favor.


Read more at Reuters.com Government Filings News